NASDAQ:SRDX - Surmodics Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $58.00
  • Forecasted Upside: 55.79 %
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$37.23
▲ +0.3 (0.81%)

This chart shows the closing price for SRDX by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Surmodics Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for SRDX and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for SRDX

Analyst Price Target is $58.00
▲ +55.79% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Surmodics in the last 3 months. The average price target is $58.00, with a high forecast of $0.00 and a low forecast of $0.00. The average price target represents a 55.79% upside from the last price of $37.23.

This chart shows the closing price for SRDX for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 1 polled investment analysts is to buy stock in Surmodics. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/6/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/6/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/5/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/3/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/1/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/1/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/31/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/30/2022

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/4/2022Needham & Company LLCLower Price TargetBuy$70.00 ➝ $58.00Low
11/10/2021Needham & Company LLCLower Price TargetBuy$76.00 ➝ $70.00High
9/8/2021Needham & Company LLCBoost Price TargetBuy$68.00 ➝ $76.00Low
2/10/2021Barrington ResearchBoost Price TargetOutperform$63.00 ➝ $70.00Low
2/5/2021Needham & Company LLCReiterated RatingBuy$61.00Low
8/6/2020Barrington ResearchReiterated RatingBuy$63.00Medium
7/23/2020Needham & Company LLCUpgradeHold ➝ Buy$61.00High
6/10/2020Barrington ResearchReiterated RatingBuy$62.00High
6/1/2020Lake Street CapitalBoost Price TargetBuy$50.00 ➝ $76.00Medium
4/30/2020Barrington ResearchReiterated RatingBuy$56.00Low
4/30/2020Needham & Company LLCReiterated RatingHoldLow
2/6/2020Barrington ResearchReiterated RatingOutperform$62.00 ➝ $56.00High
2/6/2020Lake Street CapitalUpgradeHold ➝ Buy$50.00High
2/6/2020Needham & Company LLCDowngradeHoldHigh
12/11/2019Needham & Company LLCDowngradeBuy ➝ HoldHigh
11/1/2019Barrington ResearchReiterated RatingBuy$62.00High
11/1/2019Lake Street CapitalDowngradeBuy ➝ Hold$75.00 ➝ $50.00High
8/1/2019Needham & Company LLCReiterated RatingBuy ➝ Buy$65.00 ➝ $68.00High
5/2/2019Barrington ResearchSet Price TargetBuy$64.00Low
5/2/2019Lake Street CapitalSet Price TargetBuy ➝ Buy$90.00 ➝ $75.00Low
5/2/2019Needham & Company LLCReiterated RatingBuy ➝ Buy$74.00 ➝ $65.00High
2/21/2019Needham & Company LLCReiterated RatingBuy ➝ Buy$69.00 ➝ $74.00High
1/31/2019Needham & Company LLCReiterated RatingBuy$69.00High
11/9/2018Needham & Company LLCReiterated RatingBuy$74.00High
8/23/2018Barrington ResearchBoost Price TargetOutperform$77.00Low
8/7/2018Barrington ResearchBoost Price TargetOutperform$73.00Low
8/7/2018Lake Street CapitalBoost Price TargetBuy$90.00Medium
8/6/2018Needham & Company LLCReiterated RatingBuy$74.00High
5/16/2018Needham & Company LLCBoost Price TargetBuy$46.00 ➝ $55.00High
5/3/2018Barrington ResearchBoost Price TargetOutperform$22.50 ➝ $43.00High
5/2/2018Lake Street CapitalBoost Price TargetBuy$38.00 ➝ $76.00High
3/27/2018Needham & Company LLCReiterated RatingBuy$42.00Medium
3/1/2018SidotiUpgradeNeutral ➝ BuyLow
2/28/2018Barrington ResearchUpgradeMarket Perform ➝ OutperformHigh
2/28/2018Lake Street CapitalReiterated RatingBuy ➝ Buy$35.00 ➝ $38.00Low
2/27/2018Needham & Company LLCInitiated CoverageBuy ➝ Buy$42.00Low
7/14/2017Lake Street CapitalInitiated CoverageBuy ➝ Buy$40.00Medium
(Data available from 6/30/2017 forward)

News Sentiment Rating

0.43 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/2/2021
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/1/2022
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/31/2022
  • 0 very positive mentions
  • 6 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
3/2/2022
  • 1 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/1/2022
  • 3 very positive mentions
  • 9 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
5/1/2022
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/31/2022
  • 2 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/30/2022

Current Sentiment

  • 2 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.
Surmodics logo
Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment engages in the provision of surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices; and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device for coronary, peripheral, neuro-vascular and structural heart, and other markets, as well as design, development, and manufacturing of interventional medical devices, primarily balloons and catheters, including drug-coated balloons for peripheral arterial disease treatment and other applications. The IVD segment designs, develops, and manufactures component products and technologies for diagnostic immunoassay, as well as molecular test and biomedical research applications. This segment offers protein stabilization reagents, substrates, surface coatings, and antigens. The company was founded in 1979 and is headquartered in Eden Prairie, Minnesota.
Read More

Today's Range

Now: $37.23
Low: $36.55
High: $38.00

50 Day Range

MA: $37.48
Low: $33.25
High: $42.13

52 Week Range

Now: $37.23
Low: $32.43
High: $62.27

Volume

40,917 shs

Average Volume

44,905 shs

Market Capitalization

$520.85 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.07

Frequently Asked Questions

What sell-side analysts currently cover shares of Surmodics?

The following Wall Street sell-side analysts have issued stock ratings on Surmodics in the last twelve months: Needham & Company LLC, StockNews.com, and TheStreet.
View the latest analyst ratings for SRDX.

What is the current price target for Surmodics?

0 Wall Street analysts have set twelve-month price targets for Surmodics in the last year. Their average twelve-month price target is $58.00, suggesting a possible upside of 55.8%.
View the latest price targets for SRDX.

What is the current consensus analyst rating for Surmodics?

Surmodics currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe SRDX will outperform the market and that investors should add to their positions of Surmodics.
View the latest ratings for SRDX.

How do I contact Surmodics' investor relations team?

Surmodics' physical mailing address is 9924 WEST 74TH STREET, EDEN PRAIRIE MN, 55344. The company's listed phone number is (952) 500-7000 and its investor relations email address is [email protected] The official website for Surmodics is www.surmodics.com. Learn More about contacing Surmodics investor relations.